Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Alcon Inc
(NY:
ALC
)
83.29
+0.01 (+0.01%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
648,985
Open
82.88
Bid (Size)
82.81 (1)
Ask (Size)
83.82 (1)
Prev. Close
83.28
Today's Range
83.25 - 83.51
52wk Range
67.14 - 88.23
Shares Outstanding
489,219,355
Dividend Yield
0.28%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Alcon Inc. (NYSE: ALC) Records 52-Week High Tuesday Morning
March 12, 2024
Via
Investor Brand Network
Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone
March 06, 2024
From
Alcon Inc. Corporate
Via
Business Wire
Performance
YTD
+8.11%
+8.11%
1 Month
+2.60%
+2.60%
3 Month
+6.81%
+6.81%
6 Month
+7.35%
+7.35%
1 Year
+23.25%
+23.25%
More News
Read More
Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023
February 27, 2024
From
Alcon Inc. Investors
Via
Business Wire
Earnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month
February 09, 2024
Via
Benzinga
What 6 Analyst Ratings Have To Say About Alcon
December 04, 2023
Via
Benzinga
The Latest Analyst Ratings for Alcon
November 16, 2023
Via
Benzinga
Why Medical Device Company Alcon Shares Are Sliding Today
November 15, 2023
Via
Benzinga
Buy This Ophthalmology Stock But Sell This One, Says Bernstein Analyst: 'Innovation Is Key'
January 23, 2024
Via
Benzinga
Good News For Dry Eye Disease Patients: Eye Care Focused Alcon's Treatment Shows Encouraging Benefit In Late-Stage Trials
January 10, 2024
Via
Benzinga
Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye
January 09, 2024
From
Alcon Inc. Investors
Via
Business Wire
Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
January 05, 2024
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Where Alcon Stands With Analysts
September 08, 2023
Via
Benzinga
Alcon Inc. (NYSE: ALC) Highlighted for Surprising Price Action
August 17, 2023
Via
Investor Brand Network
Alcon to Present at 2024 Annual J.P. Morgan Healthcare Conference
December 27, 2023
From
Alcon Inc. Investors
Via
Business Wire
Intel To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Thursday
November 16, 2023
Via
Benzinga
US Stocks On Track To Build On Gains As Traders Await A Batch Of Data; Can Market Resist Profit Taking?
November 15, 2023
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Varex Imaging Reports Weak Sales, Joins Alcon, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
November 15, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
November 15, 2023
Via
Benzinga
Alcon Reports Third Quarter 2023 Results
November 14, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon Gears Up For Q3 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
November 14, 2023
Via
Benzinga
Alcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023
October 30, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon Launches TOTAL30 Multifocal Contact Lenses for Patients with Presbyopia
October 10, 2023
From
Alcon Inc. Investors
Via
Business Wire
Cataract Surgery with Alcon’s AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle Dependence
September 09, 2023
From
Alcon Inc. Corporate
Via
Business Wire
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030
September 08, 2023
Via
FinancialNewsMedia
Exposures
COVID-19
Alcon Announces its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation to Support Ophthalmic Surgical Teams
September 06, 2023
From
Alcon Inc. Corporate
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.